Loading...
XTAENISA
Market cap31mUSD
Dec 24, Last price  
1,280.00ILS
1D
-0.23%
1Q
-7.25%
Jan 2017
-67.06%
Name

Nissan Medical Industries Ltd

Chart & Performance

D1W1MN
XTAE:NISA chart
P/E
2,058.22
P/S
15.84
EPS
0.62
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
2.20%
Revenues
734m
+7.20%
466,789,000512,208,000529,957,000509,478,000584,389,000658,386,000605,462,000721,481,000668,372,000684,647,000733,914,000
Net income
6m
P
46,702,000603,00037,132,00017,909,00012,709,00025,102,00015,709,00056,846,00036,012,000-36,049,0005,649,000
CFO
106m
+805.56%
72,612,00077,113,000120,183,00044,178,00052,352,00085,837,00055,764,000122,569,00017,978,00011,674,000105,715,000
Dividend
Mar 01, 202244 ILS/sh

Profile

Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.
URL
IPO date
Jan 01, 1993
Employees
386
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
733,914
7.20%
684,647
2.44%
668,372
-7.36%
Cost of revenue
649,221
666,037
580,338
Unusual Expense (Income)
NOPBT
84,693
18,610
88,034
NOPBT Margin
11.54%
2.72%
13.17%
Operating Taxes
8,781
269
13,294
Tax Rate
10.37%
1.45%
15.10%
NOPAT
75,912
18,341
74,740
Net income
5,649
-115.67%
(36,049)
-200.10%
36,012
-36.65%
Dividends
(3,997)
(9,084)
Dividend yield
5.12%
4.56%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
120,832
119,409
97,351
Long-term debt
91,792
144,075
156,917
Deferred revenue
Other long-term liabilities
52,602
5,081
8,086
Net debt
173,177
208,024
178,638
Cash flow
Cash from operating activities
105,715
11,674
17,978
CAPEX
(9,819)
(9,693)
(8,301)
Cash from investing activities
(9,925)
(9,678)
5,624
Cash from financing activities
(90,714)
(25,781)
(31,197)
FCF
83,946
(21,129)
41,215
Balance
Cash
25,052
19,508
40,155
Long term investments
14,395
35,952
35,475
Excess cash
2,751
21,228
42,211
Stockholders' equity
338,328
323,547
362,011
Invested Capital
602,895
564,912
548,098
ROIC
13.00%
3.30%
14.05%
ROCE
13.98%
2.93%
13.88%
EV
Common stock shares outstanding
9,084
9,084
9,084
Price
10.80
25.68%
8.59
-60.78%
21.91
-23.34%
Market cap
98,107
25.68%
78,059
-60.78%
199,030
-23.34%
EV
406,900
420,188
537,724
EBITDA
115,835
47,260
113,629
EV/EBITDA
3.51
8.89
4.73
Interest
21,266
10,016
7,277
Interest/NOPBT
25.11%
53.82%
8.27%